| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Shahin Rafii | |
| Ralph L Nachman | |||
| P2860 | cites work | VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling | Q22009049 |
| Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells | Q24291455 | ||
| Thermodynamics of beta-catenin-ligand interactions: the roles of the N- and C-terminal tails in modulating binding affinity | Q24295448 | ||
| Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments | Q24299236 | ||
| The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin | Q27631714 | ||
| Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis | Q28140788 | ||
| The functional role of blood platelet components in angiogenesis | Q28209386 | ||
| Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab | Q28219257 | ||
| The three-dimensional organization of tight junctions in a capillary endothelium revealed by serial-section electron microscopy | Q28270187 | ||
| IQ-domain GTPase-activating protein 1 regulates beta-catenin at membrane ruffles and its role in macropinocytosis of N-cadherin and adenomatous polyposis coli | Q28285153 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| Angiogenesis: an organizing principle for drug discovery? | Q29614538 | ||
| Endothelial/pericyte interactions | Q29619802 | ||
| Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells | Q33206200 | ||
| Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis | Q33349359 | ||
| Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis | Q33358404 | ||
| Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib | Q46735182 | ||
| Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer | Q46892024 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9. | Q48008908 | ||
| Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro | Q50335763 | ||
| Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment. | Q54579913 | ||
| VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues | Q57382249 | ||
| Dynamic Visualization of Thrombopoiesis Within Bone Marrow | Q58450371 | ||
| Bcl-2 Orchestrates a Cross-talk between Endothelial and Tumor Cells that Promotes Tumor Growth | Q62336484 | ||
| Unidirectional crosstalk between Bcl-xL and Bcl-2 enhances the angiogenic phenotype of endothelial cells | Q62336491 | ||
| Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors | Q71789644 | ||
| Positive and negative hematopoietic cytokines produced by bone marrow endothelial cells | Q73954015 | ||
| Expression of thrombopoietin by umbilical vein endothelial cells | Q74000323 | ||
| Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells | Q77850439 | ||
| Fluid shear stress enhances the sphingosine 1-phosphate responses in cell-cell interactions between platelets and endothelial cells | Q80356980 | ||
| Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes | Q33371036 | ||
| Programmed anuclear cell death delimits platelet life span. | Q33374664 | ||
| The anatomic basis of purpura | Q33483458 | ||
| Amelioration of endothelial abnormalities by prednisone in experimental thrombocytopenia in the rabbit | Q33498850 | ||
| Current biology of VEGF-B and VEGF-C. | Q33796264 | ||
| VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells | Q34035717 | ||
| The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability. | Q34075670 | ||
| Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation | Q34380698 | ||
| Autocrine VEGF signaling is required for vascular homeostasis | Q34443661 | ||
| Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. | Q34455428 | ||
| Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released | Q34584213 | ||
| Platelets in atherothrombosis | Q34986345 | ||
| The role of neuropilin in vascular and tumor biology. | Q35076249 | ||
| Radiation and ceramide-induced apoptosis | Q35208833 | ||
| Endothelial cell-cell junctions: happy together | Q35741007 | ||
| Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown | Q35791582 | ||
| Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights | Q35941009 | ||
| Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets | Q35960196 | ||
| The biology of vascular endothelial growth factors. | Q36017169 | ||
| The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin | Q36229078 | ||
| Pericytes and vascular stability | Q36319680 | ||
| Lessons from phase III clinical trials on anti-VEGF therapy for cancer | Q36366446 | ||
| Discovery of vascular permeability factor (VPF). | Q36375479 | ||
| The multiple languages of endothelial cell-to-cell communication | Q36429966 | ||
| Phospho-regulation of Beta-catenin adhesion and signaling functions. | Q36967628 | ||
| Platelet activation and atherothrombosis | Q37031278 | ||
| Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. | Q37035357 | ||
| Synthesis of Factor VIII Antigen by Cultured Guinea Pig Megakaryocytes | Q37047673 | ||
| Synthesis of von Willebrand factor by cultured human endothelial cells | Q37444356 | ||
| The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling | Q40751632 | ||
| The molecular organization of tight junctions | Q40903764 | ||
| Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells | Q41144930 | ||
| Interendothelial junctions: structure, signalling and functional roles. | Q41612546 | ||
| The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction | Q41881567 | ||
| The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis | Q42411644 | ||
| Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens | Q42805681 | ||
| VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism | Q44043571 | ||
| Osteopontin expression and adventitial angiogenesis induced by local vascular endothelial growth factor 165 reduces experimental aortic calcification | Q46283969 | ||
| Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin | Q46728817 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | petechia | Q1412657 |
| P304 | page(s) | 1261-1270 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Platelets, petechiae, and preservation of the vascular wall | |
| P478 | volume | 359 |
| Q48126340 | 24-h continuous infusion of platelets for patients with platelet transfusion refractoriness |
| Q90494935 | A Journey Upstream: Fluctuating Platelet-Specific Genes in Cell Free Plasma as Proof-of-Concept for Using RNA Sequencing to Improve Understanding of Post-Injury Platelet Biology |
| Q37432574 | A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects |
| Q33429565 | A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial |
| Q33407813 | Alternate considerations for current concepts in ITP. |
| Q52350643 | Amicus or Adversary Revisited: Platelets in Acute Lung Injury & Acute Respiratory Distress Syndrome. |
| Q37688711 | Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target? |
| Q37047000 | Bacillus anthracis peptidoglycan activates human platelets through FcγRII and complement |
| Q34593475 | Bevacizumab combined with chemotherapy for advanced non-small cell lung cancer: a meta-analysis |
| Q30525402 | Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia |
| Q33424357 | Blocking neutrophil diapedesis prevents hemorrhage during thrombocytopenia |
| Q47096645 | Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients? |
| Q34805344 | Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds |
| Q38148437 | Brain regulation of thrombosis and hemostasis: from theory to practice |
| Q95321982 | COVID-19: the vasculature unleashed |
| Q33807542 | Cardio-Oncology: Cancer Therapy-related Cardiovascular Complications in a Molecular Targeted Era: New Concepts and Perspectives |
| Q36721511 | Cardiovascular Toxicity of Molecular Targeted Therapy in Cancer Patients: A Double-Edged Sword |
| Q33396038 | Cardiovascular interventions in thrombocytopenic cancer patients |
| Q53276936 | Cardiovascular toxic effects of targeted cancer therapy. |
| Q34813136 | Cerebral microbleeds in the elderly: a pathological analysis |
| Q35599819 | Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors. |
| Q83395977 | Comment on: Dengue mortality: reassessing the risks in transition countries |
| Q38286128 | Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy |
| Q37831798 | Contribution of platelets to tumour metastasis. |
| Q24645380 | Dengue virus pathogenesis: an integrated view |
| Q64117962 | Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue |
| Q24198832 | Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation |
| Q24186359 | Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation |
| Q83026961 | Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer |
| Q30494712 | Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis |
| Q54970116 | Dual antiplatelet therapy with clopidogrel and aspirin increases mortality in 4T1 metastatic breast cancer-bearing mice by inducing vascular mimicry in primary tumour. |
| Q38284439 | Early treatment with rutoside and ascorbic acid is highly effective for progressive pigmented purpuric dermatosis |
| Q36122760 | Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: A pilot randomized controlled trial. |
| Q44877409 | Endothelial alterations in a canine model of immune thrombocytopenia. |
| Q58571918 | Endothelial-Vascular Smooth Muscle Cells Interactions in Atherosclerosis |
| Q35694069 | Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis |
| Q34674369 | Expression of regulatory platelet microRNAs in patients with sickle cell disease |
| Q38341556 | Gene expression profiling in peripheral blood nuclear cells in patients with refractory ischaemic end-stage heart failure. |
| Q30240053 | How do we approach thrombocytopenia in critically ill patients? |
| Q35588157 | How platelets safeguard vascular integrity |
| Q26997803 | Human platelets and their capacity of binding viruses: meaning and challenges? |
| Q33403135 | Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability |
| Q27342617 | Impaired integrin β3 delays endothelial cell regeneration and contributes to arteriovenous graft failure in mice |
| Q53317633 | In vitro evaluation of the hemostatic effectiveness of cryopreserved platelets. |
| Q33386103 | Innate immune cells induce hemorrhage in tumors during thrombocytopenia |
| Q33413225 | Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocol |
| Q84791878 | Intravitreous VEGF-A in eyes with massive vitreous hemorrhage |
| Q33437777 | Management of severe dengue hemorrhagic fever and bleeding complications in a primigravida patient: a case report |
| Q26862087 | Megakaryocytes, malignancy and bone marrow vascular niches |
| Q38495085 | Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions. |
| Q38749029 | Paper-based point-of-care testing for diagnosis of dengue infections |
| Q33753094 | Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis |
| Q89471812 | Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury |
| Q34765904 | Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkers |
| Q37932076 | Platelet activation in obesity and metabolic syndrome |
| Q38281989 | Platelet secretion: From haemostasis to wound healing and beyond |
| Q37982455 | Platelet signaling-a primer. |
| Q33395509 | Platelet transfusions for patients with haematological malignancies: who needs them? |
| Q35829738 | Platelet-rich plasma peptides: key for regeneration |
| Q90403621 | Platelets Are at the Nexus of Vascular Diseases |
| Q33440142 | Platelets and infections in the resource-limited countries with a focus on malaria and viral haemorrhagic fevers |
| Q34590168 | Platelets as immune mediators: Their role in host defense responses and sepsis |
| Q55004062 | Platelets in Immune Response to Virus and Immunopathology of Viral Infections. |
| Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
| Q26852677 | Platelets in inflammation: regulation of leukocyte activities and vascular repair |
| Q36897267 | Platelets in lung biology. |
| Q33404240 | Platelets in pulmonary vascular physiology and pathology |
| Q36070471 | Platelets induce apoptosis via membrane-bound FasL. |
| Q37398523 | Platelets regulate vascular endothelial stability: assessing the storage lesion and donor variability of apheresis platelets. |
| Q89950822 | Platelets, Micro-Particles and Elastase. A Review with Extrapolation to the Mechanism of Generation and Bio-Pathology of Platelet Fragments |
| Q84066488 | Platelets, oxidative stress and preservation of the vascular endothelium: is it a matter of fat? |
| Q39248498 | Platelets: much more than bricks in a breached wall. |
| Q92717119 | Prediction of Ticagrelor and its Active Metabolite in Liver Cirrhosis Populations Using a Physiologically Based Pharmacokinetic Model Involving Pharmacodynamics |
| Q64096001 | Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation |
| Q24197779 | Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation |
| Q41863261 | Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw |
| Q42946822 | Ramping up RANTES in the acute response to arterial injury |
| Q36409037 | S1P and the birth of platelets. |
| Q38834645 | Smart blood cell and microvesicle-based Trojan horse drug delivery: Merging expertise in blood transfusion and biomedical engineering in the field of nanomedicine |
| Q90289537 | Spontaneous bleeding in thrombocytopenia: Is it really spontaneous? |
| Q46015443 | The effects of 22°C and 4°C storage of platelets on vascular endothelial integrity and function. |
| Q38212058 | The functional role of platelets in the regulation of angiogenesis |
| Q63407979 | The physiological and pathophysiological roles of platelet CLEC-2 |
| Q92222177 | Transforming Endothelium with Platelet-Rich Plasma in Engineered Microvessels |
| Q50115928 | Translational Implications of Platelets as Vascular First Responders |
| Q35022509 | Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice, and knowledge gaps |
| Q93082879 | Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles |
| Q91596480 | Unexpected effects of long-term treatment with acetylsalicylic acid on late phase of pulmonary metastasis in murine model of orthotopic breast cancer |
| Q92257481 | Vascularized Microfluidics and the Blood-Endothelium Interface |
| Q90392500 | α-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis |
Search more.